{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:02:41Z","timestamp":1768834961248,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.cyto.2018.12.001","type":"journal-article","created":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T04:18:42Z","timestamp":1544933922000},"page":"154608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Editorial: Cytokines in liver diseases"],"prefix":"10.1016","volume":"124","author":[{"given":"Subburaj","family":"Ilangumaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Moriggl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhan V.","family":"Kalvakolanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.12.001_b0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00042737-200107000-00004","article-title":"Cytokines in the liver","volume":"13","author":"Ramadori","year":"2001","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2018.12.001_b0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbadis.2012.09.014","article-title":"Cytokine mediated tissue fibrosis","volume":"1832","author":"Borthwick","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cyto.2018.12.001_b0015","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2018.12.001_b0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2018.12.001_b0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver \u2013 from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2018.12.001_b0030","first-page":"297","article-title":"Interleukins in chronic liver disease: lessons learned from experimental mouse models","volume":"7","author":"Hammerich","year":"2014","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.cyto.2018.12.001_b0035","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","article-title":"The 3 major types of innate and adaptive cell-mediated effector immunity","volume":"135","author":"Annunziato","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2018.12.001_b0040","article-title":"Type 3 cytokines in liver fibrosis and liver cancer","author":"Molina","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.12.001_b0045","first-page":"1","article-title":"SOCS proteins in development and disease","volume":"2","author":"Trengove","year":"2013","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2018.12.001_b0050","article-title":"Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis","author":"Mafanda","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.12.001_b0055","article-title":"Different core-specific T cell subsets are expanded in chronic hepatitis C with advanced liver disease","author":"Cachem","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.12.001_b0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cyto.2018.12.001_b0065","article-title":"Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity","author":"Gupta","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.12.001_b0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2018.12.001_b0075","article-title":"Hepatic growth hormone \u2013 JAK2 \u2013 STAT5 signalling: metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression","author":"Kaltenecker","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.12.001_b0080","article-title":"STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice","author":"Kaltenecker","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.12.001_b0085","article-title":"The role of IFN in the development of NAFLD and NASH","author":"Mohlenberg","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.12.001_b0090","article-title":"Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma","author":"Mani","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.12.001_b0095","article-title":"IL-15 and IFN-gamma signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling","author":"Vahedi","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.12.001_b0100","article-title":"Crosstalk between inflammatory mediators and endoplasmic reticulum stress in liver diseases","author":"Duvigneau","year":"2018","journal-title":"Cytokine"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618304666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618304666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T21:20:05Z","timestamp":1571779205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618304666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":20,"alternative-id":["S1043466618304666"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.12.001","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial: Cytokines in liver diseases","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154608"}}